Tempus, a precision medicine company, raised $100 million in Series G financing round at a post-money valuation of $5 billion. Investors include: The investors include
Concerto HealthAI Raises $150 million in Series B Financing
Concerto HealthAI, a provider of enterprise artificial intelligence and real-world data solutions for precision oncology, raised $150 million in aggregate Series B financing. Declaration Partners,